[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Multiplex Immunofluorescence Assay Industry Research Report 2023

August 2023 | 62 pages | ID: M679B0CCFA2AEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights

The global Multiplex Immunofluorescence Assay market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

North American market for Multiplex Immunofluorescence Assay is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Asia-Pacific market for Multiplex Immunofluorescence Assay is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The major global companies of Multiplex Immunofluorescence Assay include Fluidigm and Akoya Biosciences etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

The global market for Multiplex Immunofluorescence Assay in Academic and Research Institution is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Material, which accounted for % of the global market of Multiplex Immunofluorescence Assay in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Multiplex Immunofluorescence Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Immunofluorescence Assay.

The Multiplex Immunofluorescence Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multiplex Immunofluorescence Assay market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Multiplex Immunofluorescence Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Fluidigm
  • Akoya Biosciences
Product Type Insights

Global markets are presented by Multiplex Immunofluorescence Assay type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Multiplex Immunofluorescence Assay are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Multiplex Immunofluorescence Assay segment by Type
  • Material
  • Equipment
  • Software and Service
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Multiplex Immunofluorescence Assay market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Multiplex Immunofluorescence Assay market.

Multiplex Immunofluorescence Assay Segment by Application
  • Academic and Research Institution
  • Hospital
  • Others
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Multiplex Immunofluorescence Assay market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Immunofluorescence Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Multiplex Immunofluorescence Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Multiplex Immunofluorescence Assay industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Immunofluorescence Assay.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Multiplex Immunofluorescence Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Multiplex Immunofluorescence Assay by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 Material
  1.2.3 Equipment
  1.2.4 Software and Service
2.3 Multiplex Immunofluorescence Assay by Application
  2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
  2.3.2 Academic and Research Institution
  2.3.3 Hospital
  2.3.4 Others
2.4 Assumptions and Limitations

3 MULTIPLEX IMMUNOFLUORESCENCE ASSAY BREAKDOWN DATA BY TYPE

3.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Type (2018-2023)
3.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Type (2023-2028)

4 MULTIPLEX IMMUNOFLUORESCENCE ASSAY BREAKDOWN DATA BY APPLICATION

4.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Application (2018-2023)
4.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Application (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global Multiplex Immunofluorescence Assay Market Perspective (2018-2029)
5.2 Global Multiplex Immunofluorescence Assay Growth Trends by Region
  5.2.1 Global Multiplex Immunofluorescence Assay Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 Multiplex Immunofluorescence Assay Historic Market Size by Region (2018-2023)
  5.2.3 Multiplex Immunofluorescence Assay Forecasted Market Size by Region (2024-2029)
5.3 Multiplex Immunofluorescence Assay Market Dynamics
  5.3.1 Multiplex Immunofluorescence Assay Industry Trends
  5.3.2 Multiplex Immunofluorescence Assay Market Drivers
  5.3.3 Multiplex Immunofluorescence Assay Market Challenges
  5.3.4 Multiplex Immunofluorescence Assay Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue
  6.1.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue (2018-2023)
  6.1.2 Global Multiplex Immunofluorescence Assay Revenue Market Share by Players (2018-2023)
6.2 Global Multiplex Immunofluorescence Assay Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Multiplex Immunofluorescence Assay Head office and Area Served
6.4 Global Multiplex Immunofluorescence Assay Players, Product Type & Application
6.5 Global Multiplex Immunofluorescence Assay Players, Date of Enter into This Industry
6.6 Global Multiplex Immunofluorescence Assay Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Multiplex Immunofluorescence Assay Market Size (2018-2029)
7.2 North America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
7.4 North America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Multiplex Immunofluorescence Assay Market Size (2018-2029)
8.2 Europe Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
8.4 Europe Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size (2018-2029)
9.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
9.4 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Multiplex Immunofluorescence Assay Market Size (2018-2029)
10.2 Latin America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
10.4 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size (2018-2029)
11.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
11.4 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Fluidigm
  11.1.1 Fluidigm Company Detail
  11.1.2 Fluidigm Business Overview
  11.1.3 Fluidigm Multiplex Immunofluorescence Assay Introduction
  11.1.4 Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2017-2022)
  11.1.5 Fluidigm Recent Development
11.2 Akoya Biosciences
  11.2.1 Akoya Biosciences Company Detail
  11.2.2 Akoya Biosciences Business Overview
  11.2.3 Akoya Biosciences Multiplex Immunofluorescence Assay Introduction
  11.2.4 Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2017-2022)
  11.2.5 Akoya Biosciences Recent Development

13 REPORT CONCLUSION


14 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Multiplex Immunofluorescence Assay Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Multiplex Immunofluorescence Assay Revenue Market Share by Type (2018-2023)
Table 7. Global Multiplex Immunofluorescence Assay Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Multiplex Immunofluorescence Assay Revenue Market Share by Type (2024-2029)
Table 9. Global Multiplex Immunofluorescence Assay Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Multiplex Immunofluorescence Assay Revenue Market Share by Application (2018-2023)
Table 11. Global Multiplex Immunofluorescence Assay Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Multiplex Immunofluorescence Assay Revenue Market Share by Application (2024-2029)
Table 13. Global Multiplex Immunofluorescence Assay Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Multiplex Immunofluorescence Assay Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Multiplex Immunofluorescence Assay Market Share by Region (2018-2023)
Table 16. Global Multiplex Immunofluorescence Assay Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Multiplex Immunofluorescence Assay Market Share by Region (2024-2029)
Table 18. Multiplex Immunofluorescence Assay Market Trends
Table 19. Multiplex Immunofluorescence Assay Market Drivers
Table 20. Multiplex Immunofluorescence Assay Market Challenges
Table 21. Multiplex Immunofluorescence Assay Market Restraints
Table 22. Global Top Multiplex Immunofluorescence Assay Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Multiplex Immunofluorescence Assay Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Multiplex Immunofluorescence Assay Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Multiplex Immunofluorescence Assay, Headquarters and Area Served
Table 26. Global Multiplex Immunofluorescence Assay Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Multiplex Immunofluorescence Assay by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2024-2029) & (US$ Million)
Table 45. Fluidigm Company Detail
Table 46. Fluidigm Business Overview
Table 47. Fluidigm Multiplex Immunofluorescence Assay Product
Table 48. Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2017-2022) & (US$ Million)
Table 49. Fluidigm Recent Development
Table 50. Akoya Biosciences Company Detail
Table 51. Akoya Biosciences Business Overview
Table 52. Akoya Biosciences Multiplex Immunofluorescence Assay Product
Table 53. Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2017-2022) & (US$ Million)
Table 54. Akoya Biosciences Recent Development
Table 55. Fluidigm Company Information
Table 56. Fluidigm Business Overview
Table 57. Fluidigm Multiplex Immunofluorescence Assay Revenue in Multiplex Immunofluorescence Assay Business (2018-2023) & (US$ Million)
Table 58. Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2018-2023) & (US$ Million) Portfolio
Table 59. Fluidigm Recent Development
Table 60. Akoya Biosciences Company Information
Table 61. Akoya Biosciences Business Overview
Table 62. Akoya Biosciences Multiplex Immunofluorescence Assay Revenue in Multiplex Immunofluorescence Assay Business (2018-2023) & (US$ Million)
Table 63. Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2018-2023) & (US$ Million) Portfolio


More Publications